Classification and severity progression measure of COVID-19 patients using pairs of multi-omic factors

References

• N. Agresti, J.P. Lalezari, P.P. Amodeo, K. Mody, S.F. Mosher, H. Seethamraju, S.A. Kelly, N.Z. Pourhassan, C.D. Sudduth, C. Bovinet, A.E. ElSharkawi, B.K. Patterson, R. Stephen, J.B. Sacha, H.L. Wu, S.A. Gross and K. Dhody, Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: case series of four critically ill patients treated with leronlimab, Journal of Translational Autoimmunity 4 (2021), p. 100083.
   PubMedGoogle Scholar
• J.H. Ahlberg, E.N. Nilson and J.L. Walsh, The theory of splines and their applications, in Mathematics in Science and Engineering, A Series of Monographs and Textbooks, Vol. 38, New York, Elsevier, 2016.
   Google Scholar
• S. Ahmad, M.H. Ma'mon, L. Lambuk, M.A. Al-Hatamleh, W. Alshaer and R. Mohamud, The role of TNFR2+ Tregs in COVID-19: an overview and a potential therapeutic strategy, Life Sci. 286 (2021), p. 120063.
   PubMed Web of Science ®Google Scholar
• E. Akgun, M.B. Tuzuner, B. Sahin, M. Kilercik, C. Kulah, H.N. Cakiroglu, M. Serteser, I. Unsal and A.T. Baykal, Proteins associated with neutrophil degranulation are upregulated in nasopharyngeal swabs from SARS-CoV-2 patients, PLoS ONE 15 (2020), p. e0240012.
   PubMed Web of Science ®Google Scholar
• M.R. Auwul, M.R. Rahman, E. Gov, M. Shahjaman and M.A. Moni, Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19, Brief. Bioinformatics. 22 (2021), pp. 1–13.
   PubMed Web of Science ®Google Scholar
• A. Bharat, M. Querrey, N.S. Markov, S. Kim, C. Kurihara, R. Garza-Castillon, A. Manerikar, A. Shilatifard, R. Tomic, Y. Politanska, H. Abdala-Valencia, A.V. Yeldandi, J.W. Lomasney, A.V. Misharin and G.R. Scott Budinger, Lung transplantation for patients with severe COVID-19, Sci. Transl. Med. 12 (2020), p. eabe4282.
   PubMed Web of Science ®Google Scholar
• P. Bost, A. Giladi, Y. Liu, Y. Bendjelal, G. Xu, E. David, R. Blecher-Gonen, M. Cohen, C. Medaglia, H. Li, A. Deczkowska, S. Zhang, B. Schwikowski, Z. Zhang and I. Amit, Host-viral infection maps reveal signatures of severe COVID-19 patients, Cell 181 (2020), pp. 1475–1488.
   PubMed Web of Science ®Google Scholar
• J.D. Breidenbach, P. Dube, S. Ghosh, B.N. Abdullah, N.N. Modyanov, D. Malhotra, L.D. Dworkin, S.T. Haller and D.J. Kennedy, Impact of comorbidities on SARS-CoV-2 viral entry-related genes, J. Pers. Med. 10 (2020), p. 146.
   PubMed Web of Science ®Google Scholar
• R.L. Chua, S. Lukassen, S. Trump, B.P. Hennig, D. Wendisch, F. Pott, O. Debnath, L. Thürmann, F. Kurth, M.T. Völker, J. Kazmierski, B. Timmermann, S. Twardziok, S. Schneider, F. Machleidt, H. Müller-Redetzky, M. Maier, A. Krannich, S. Schmidt, F. Balzer, J. Liebig, J. Loske, N. Suttorp, J. Eils, N. Ishaque, U. Gerd Liebert, C. von Kalle, A. Hocke, M. Witzenrath, C. Goffinet, C. Drosten, S. Laudi, I. Lehmann, C. Conrad, L. Sander and R. Eils, COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis, Nat. Biotechnol. 38 (2020), pp. 970–979.
   PubMed Web of Science ®Google Scholar
• L.G. De Almeida Chuffa, P.P. Freire, J. Dos Santos Souza, M.C. de Mello, M. de Oliveira Neto and R.F. Carvalho, Aging whole blood transcriptome reveals candidate genes for SARS-CoV-2-related vascular and immune alterations, J. Molecular Med. 100 (2021), pp. 285–301.
   PubMed Web of Science ®Google Scholar
• M.N. Djekidel, W. Rosikiewicz, J.C. Peng, T.-D. Kanneganti, Y. Hui, H. Jin, D. Hedges, P. Schreiner, Y. Fan, G. Wu and B. Xu, CovidExpress: an interactive portal for intuitive investigation on SARS-CoV-2 related transcriptomes, bioRxiv, 2021a.
   Google Scholar
• M.N. Djekidel, W. Rosikiewicz, J.C. Peng, T.-D. Kanneganti, Y. Hui, H. Jin, D. Hedges, P. Schreiner, Y. Fan, G. Wu and B. Xu, Single-cell RNA sequencing analysis of human kidney reveals the presence of ACE2 receptor: a potential pathway of COVID-19 infection, bioRxiv, 2021b.
   Google Scholar
• K.-Y. Fang, G.-N. Liang, Z.-Q. Zhuang, Y.-X. Fang, Y.-Q. Dong, C.-J. Liang, X.-Y. Chen and X. Guo, Screening the hub genes and analyzing the mechanisms in discharged COVID-19 patients retesting positive through bioinformatics analysis, Research Square, 2021.
   Google Scholar
• A. Farshbaf, N. Mohtasham, R. Zare, F. Mohajertehran and S.A. Rezaee, Potential therapeutic approaches of microRNAs for COVID-19: challenges and opportunities, J. Oral. Biol. Craniofac. Res. 11 (2021), pp. 132–137.
   PubMedGoogle Scholar
• T. Fazolo, K. Lima, J.C. Fontoura, P.O. de Souza, G. Hilario, R. Zorzetto, L.R. Júnior, V.M. Pscheidt, J. de Castilhos Ferreira Neto, A.F. Haubert, I. Gambin, A.C. Oliveira, R.S. Mello, M. de Bastos Balbe e Gutierres, R. Benedetti Gassen, L. Durço Coimbra, A. Borin, R.E. Marques, I.T.S. Sartor, G.O. Zavaglia, I.R. Fernandes, H.I. Nakaya, F.H. Varela, M. Polese-Bonatto, T.J. Borges, S.M. Callegari-Jacques, M.S. da Costa, J. de Araujo Schwartz, M.C. Scotta, R.T. Stein and C. Bonorino, Pediatric COVID-19 patients in south Brazil show abundant viral mRNA and strong specific anti-viral responses, Nat. Commun. 12 (2021), pp. 1–13.
   PubMed Web of Science ®Google Scholar
• M.R. Filbin, A. Mehta, A.M. Schneider, K.R. Kays, J.R. Guess, M. Gentili, B.G. Fenyves, N.C. Charland, A.L. Gonye, I. Gushterova, H.K. Khanna, T.J. LaSalle, K.M. Lavin-Parsons, B.M. Lilley, C.L. Lodenstein, K. Manakongtreecheep, J.D. Margolin, B.N. McKaig, M. Rojas-Lopez, B.C. Russo, N. Sharma, J. Tantivit, M.F. Thomas, R.E. Gerszten, G.S. Heimberg, P.J. Hoover, D.J. Lieb, B. Lin, D. Ngo, K. Pelka, M. Reyes, C.S. Smillie, A. Waghray, T.E. Wood, A.S. Zajac, L.L. Jennings, I. Grundberg, R.P. Bhattacharyya, B. Alden Parry, A. Villani, M. Sade-Feldman, N. Hacohen and M.B. Goldberg, Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions, Cell Rep. Med. 2 (2021), p. 100287.
   PubMedGoogle Scholar
• S. Galván-Peña, J. Leon, K. Chowdhary, D.A. Michelson, B. Vijaykumar, L. Yang, A.M. Magnuson, F. Chen, Z. Manickas-Hill, A. Piechocka-Trocha, D.P. Worrall, K.E. Hall, M. Ghebremichael, B.D. Walker, J.Z. Li, X.G. Yu, D. Mathis and C. Benoist, Profound treg perturbations correlate with COVID-19 severity, Proc. Natl Acad. Sci. 118 (2021), pp. 1–9.
   PubMed Web of Science ®Google Scholar
• J. Gebicki and M. Wieczorkowska, COVID-19 infection: mitohormetic concept of immune response, Cell. Death Discov. 6 (2020), pp. 1–2.
   Web of Science ®Google Scholar
• J.R. Giudicessi, D.M. Roden, A.A. Wilde and M.J. Ackerman, Genetic susceptibility for COVID-19–associated sudden cardiac death in African Americans, Heart. Rhythm. 17 (2020), pp. 1487–1492.
   PubMed Web of Science ®Google Scholar
• J. Gómez, E. Cuesta-Llavona, G.M. Albaiceta, M. García-Clemente, C. López-Larrea, L. Amado, I. López-Alonso, T. Hermida, A. Enriquez, H. Gil, B. Alonso, S. Iglesias, B. Suarez-Alvarez, V. Alvarez and E. Coto, The CCR5-Delta32 variant might explain part of the association between COVID-19 and the Chemokine-Receptor gene cluster, medRxiv, 2020.
   Google Scholar
• A. Gomez-Cadena, L. Spehner, M. Kroemer, M.B. Khelil, K. Bouiller, G. Verdeil, S. Trabanelli, C. Borg, R. Loyon and C. Jandus, Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment, Cell. Mol. Immunol. 18 (2021), pp. 484–486.
   PubMed Web of Science ®Google Scholar
• A. Gómez-Carballa, I. Rivero-Calle, J. Pardo-Seco, J. Gómez-Rial, C. Rivero-Velasco, N. Rodríguez-Núñez, G. Barbeito-Castiñeiras, H. Pérez-Freixo, M. Cebey-López, R. Barral-Arca, C. Rodriguez-Tenreiro, A. Dacosta-Urbieta, X. Bello, S. Pischedda, M.J. Currás-Tuala, S. Viz-Lasheras, F. Martinón-Torres and A. Salas, A multi-tissue study of immune gene expression profiling highlights the key role of the Nasal epithelium in COVID-19 severity, Environmental Res. 210 (2021), p. 112890.
   Web of Science ®Google Scholar
• R.K. Gupta, E.L. Nwachuku, B.E. Zusman, R.M. Jha and A.M. Puccio, Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium, PLoS ONE 16 (2021), p. e0257784.
   PubMed Web of Science ®Google Scholar
• L. Han, X. Wei, C. Liu, G. Volpe, Z. Wang, T. Pan, Y. Yuan, Y. Lei, Y. Lai, C. Ward and Y. Yu, Single-cell atlas of a non-human primate reveals new pathogenic mechanisms of COVID-19, BioRxiv, 2020.
   Google Scholar
• T. Hastie and R Tibshirani, Generalized additive models, Statist. Sci. 1 (1986), pp. 297–310.
   Google Scholar
• S. Hazra, A.G. Chaudhuri, B.K. Tiwary and N. Chakrabarti, Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: a network-based meta-analysis, Life Sci. 257 (2020), p. 118096.
   PubMed Web of Science ®Google Scholar
• N. Hemmat, A. Derakhshani, H. Bannazadeh Baghi, N. Silvestris, B. Baradaran and S. De Summa, Neutrophils, crucial, or harmful immune cells involved in coronavirus infection: a bioinformatics study, Front. Genet. 11 (2020), p. 641.
   PubMed Web of Science ®Google Scholar
• T.K. Ho, Random Decision Forests, Proceedings of 3rd International Conference on Document Analysis and Recognition, Vol. 1, New York City, IEEE, 1995, pp. 278–282.
   Google Scholar
• D.W. Hosmer and S. Lemeshow, Applied logistic regression, Hoboken, NJ, John Wiley and Sons, 2000.
   Google Scholar
• J.A. Hubacek, L. Dusek, O. Majek, V. Adamek, T. Cervinkova, D. Dlouha, J. Pavel and V. Adamkova, CCR5Δ32 deletion as a protective factor in czech first-wave COVID-19 subjects, Physiol. Res. 70 (2021), pp. 111–115.
   PubMed Web of Science ®Google Scholar
• S. Jung, I. Potapov, S. Chillara and A. Del Sol, Leveraging systems biology for predicting modulators of inflammation in patients with COVID-19, Sci. Adv. 7 (2021), p. eabe5735.
   PubMed Web of Science ®Google Scholar
• H. Kondo, T. Kageyama, S. Tanaka, S.-I. Tsukumo, K. Otsuka, Y. Mashimo, Y. Onouchi, H. Nakajima and K. Yasutomo, Markers of memory CD8 T cells depicting the effect of the BNT162b2 mRNA COVID-19 Vaccine in Japan, 2021.
   Google Scholar
• V. Kumar, How could we forget immunometabolism in SARS-CoV2 infection or COVID-19? Int. Rev. Immunol. 40 (2021), pp. 72–107.
   PubMed Web of Science ®Google Scholar
• A. Kusnadi, C. Ramírez-Suástegui, V. Fajardo, S.J. Chee, B.J. Meckiff, H. Simon, E. Pelosi, G. Seumois, F. Ay, P. Vijayanand and C.H. Ottensmeier, Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8+ T cells, Sci. Immunol. 6 (2021), p. eabe4782.
   PubMed Web of Science ®Google Scholar
• E. Kvedaraite, L. Hertwig, I. Sinha, A. Ponzetta, I.H. Myrberg, M. Lourda, M. Dzidic, M. Akber, J. Klingström, E. Folkesson, J. Rao Muvva, P. Chen, S. Gredmark-Russ, S. Brighenti, A. Norrby-Teglund, L.I. Eriksson, O. Rooyackers, S. Aleman, K. Strålin, H. Ljunggren, F. Ginhoux, N.K. Björkström, J. Henter, M. Svensson, Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity, Proc. Natl Acad. Sci. 118 (2021), p. e2018587118.
   PubMed Web of Science ®Google Scholar
• M.T.Y. Lam, S.H. Duttke, M.F. Odish, H.D. Le, E.A. Hansen, C.T. Nguyen, S. Trescott, R. Kim, S. Deota, M.W. Chang, A. Patel, M. Hepokoski, M. Alotaibi, M. Rolfsen, K. Perofsky, A.S. Warden, J. Foley, S.I. Ramirez, J.M. Dan, R.K. Abbott, S. Crotty, L.E. Crotty Alexander, A. Malhotra, S. Panda, C.W. Benner and N.G. Coufal, Profiling transcription initiation in peripheral leukocytes reveals severity-associated cis-regulatory elements in critical COVID-19, bioRxiv, 2021.
   Google Scholar
• C. Lapina, M. Rodic, D. Peschanski and S. Mesmoudi, The potential genetic network of human brain SARS-CoV-2 infection, bioRxiv, 2020.
   Google Scholar
• J.S. Lee, S. Park, H.W. Jeong, J.Y. Ahn, S.J. Choi, H. Lee, B. Choi, S.K. Nam, M. Sa, J.-S. Kwon, S.J. Jeong, H.K. Lee, S.H. Park, S.-H. Park, J.Y. Choi, S.-H. Kim, I. Jung and E.-C. Shin, Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19, Sci. Immunol. 5 (2020), p. eabd1554.
   PubMed Web of Science ®Google Scholar
• S.A. Lewis, S. Sureshchandra, M.Z. Zulu, B. Doratt, A. Pinski, M. Curtis, A. Jankeel, I. Ibraim, N. Rhoades, X. Jiang, D. Tifrea, F. Zaldivar, W. Shen, R. Edwards, D. Chow, D. Cooper, A. Amin and I. Messaoudi, Longitudinal analyses reveal age-specific immune correlates of COVID-19 severity, medRxiv, 2021.
   Google Scholar
• Y. Li, Y. Ke, X. Xia, Y. Wang, F. Cheng, X. Liu, X. Jin, B. Li, C. Xie, S. Liu, S. Liu, W. Chen, C. Yang, Y. Niu, R. Jia, Y. Chen, X. Liu, Z. Wang, F. Zheng, Y. Jin, Z. Li, N. Yang, P. Cao, H. Chen, J. Ping, F. He, C. Wang and G. Zhou, Genome-wide association study of COVID-19 severity among the chinese population, Cell. Discov. 7 (2021), pp. 1–16.
   PubMed Web of Science ®Google Scholar
• M. Liao, Y. Liu, J. Yuan, Y. Wen, G. Xu, J. Zhao, L. Cheng, J. Li, X. Wang, F. Wang, L. Liu, I. Amit, S. Zhang and Z. Zhang, Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19, Nat. Med. 26 (2020), pp. 842–844.
   PubMed Web of Science ®Google Scholar
• Z. Liu, J. Wang, Y. Xu, M. Guo, K. Mi, R. Xu, Y. Pei, Q. Zhang, X. Luan, Z. Hu and X. Liu, Implications of the Virus-Encoded miRNA and host miRNA in the pathogenicity of SARS-CoV-2, preprint (2020), arXiv:2004.04874.
   Google Scholar
• J.L. Marston, M. Greenig, M. Singh, M.L. Bendall, R.R. Duarte, C. Feschotte, L.P. Iñiguez and D.F Nixon, SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements, JCI Insight 6 (2021), p. e147170.
   PubMed Web of Science ®Google Scholar
• O.J. McElvaney, B.D. Hobbs, D. Qiao, O.F. McElvaney, M. Moll, N.L. McEvoy, J. Clarke, E. O'Connor, S. Walsh, M.H. Cho, G.F. Curley and N.G. McElvaney, A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19, EBioMedicine 61 (2020), p. 103026.
   PubMed Web of Science ®Google Scholar
• S. Mo, L. Dai, Y. Wang, B. Song, Z. Yang and W. Gu, Comprehensive analysis of the systemic transcriptomic alternations and inflammatory response during the occurrence and progress of COVID-19, Oxid. Med. Cellular Longevity 2021 (2021), p. 9998697.
   PubMed Web of Science ®Google Scholar
• S. Moolamalla, R. Balasubramanian, R. Chauhan, U.D. Priyakumar and P. Vinod, Host metabolic reprogramming in response to SARS-CoV-2 infection: a systems biology approach, Microb. Pathog. 158 (2021), p. 105114.
   PubMed Web of Science ®Google Scholar
• S. Murthy, C.D. Gomersall and R.A. Fowler, Care for critically ill patients with COVID-19, JAMA Insights 323 (2020), pp. 1499–1500.
   Google Scholar
• A. Onoja, N. Picchiotti, C. Fallerini, M. Baldassarri, F. Fava, F. Colombo, F. Chiaromonte, A. Renieri, S. Furini and F. Raimondi, An explainable model of host genetic interactions linked to COVID-19 severity, Res. Square 1 (2021), pp. 1–35.
   Google Scholar
• K.A. Overmyer, E. Shishkova, I.J. Miller, J. Balnis, M.N. Bernstein, T.M. Peters-Clarke, J.G. Meyer, Q. Quan, L.K. Muehlbauer, E.A. Trujillo, Y. He, A. Chopra, H.C. Chieng, A. Tiwari, M.A. Judson, B. Paulson, D.R. Brademan, Y. Zhu and A. Jaitovich, Large-scale multi-omic analysis of COVID-19 severity, Cell Syst. 12 (2020), pp. 23–40.
   PubMed Web of Science ®Google Scholar
• B.K. Patterson, J. Guevara-Coto, R. Yogendra, E.B. Francisco, E. Long, A. Pise, H. Rodrigues, P. Parikh, J. Mora and R.A. Mora-Rodríguez, Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning, Front. Immunol. 12 (2021a), p. 2520.
   Web of Science ®Google Scholar
• B.K. Patterson, H. Seethamraju, K. Dhody, M.J. Corley, K. Kazempour, J. Lalezari, A.P. Pang, C. Sugai, E. Mahyari, E.B. Francisco, A. Pise, H. Rodrigues, H.L. Wu, G.M. Webb, B.S. Park, S. Kelly, N. Pourhassan, A. Lelic, L. Kdouh, M. Herrera, E. Hall, B.N. Bimber, M. Plassmeyer, R. Gupta, O. Alpan, J.A. O'Halloran, P.A. Mudd, E. Akalin, L.C. Ndhlovu and J.B. Sacha, CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14, Int. J. Infect. Dis. 103 (2021b), pp. 25–32.
   PubMed Web of Science ®Google Scholar
• V. Puri, A. Arora and S. Puri, Identification of the potential molecular biomarkers of COVID-19 and the associated drugs: a bioinformatics approach, J. Adv. Sci. Res. 12 (2021).
   Google Scholar
• P. Ramesh, S. Veerappapillai and R. Karuppasamy, Gene expression profiling of corona virus microarray datasets to identify crucial targets in COVID-19 patients, Gene Rep. 22 (2021), p. 100980.
   PubMed Web of Science ®Google Scholar
• X. Ren, W. Wen, X. Fan, W. Hou, B. Su, P. Cai, J. Li, Y. Liu, F. Tang, F. Zhang and Y. Yang, COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas, Cell 184 (2021), pp. 1895–1913.
   PubMed Web of Science ®Google Scholar
• G.H. Roberts, D.S. Park, M.V. Coignet, S.R. McCurdy, S.C. Knight, R. Partha, B. Rhead, M. Zhang, N. Berkowitz, A.K.H. Baltzell, H. Guturu, A.R. Girshick, K.A. Rand, E.L. Hong and C.A. Ball, AncestryDNA COVID-19 host genetic study identifies three novel loci, medRxiv, 2020.
   Google Scholar
• N.S. Sahajpal, C.-Y.J. Lai, A. Hastie, A.K. Mondal, S.R. Dehkordi, C. van der Made, O. Fedrigo, F. Al-Ajli, S. Jalnapurkar, R. Kanagal-Shamanna, B. Levy, S.-A. Bacanu, M.C. Zody, C.A. Brownstein, A.M. Rojiani, A.H. Beggs, V. Bafna, A. Hoischen, E.D. Jarvis, A. Chaubey and R. Kolhe, Host genome analysis of structural variations by optical genome mapping provides clinically valuable insights into genes implicated in critical immune, viral infection, and viral replication pathways in patients with severe COVID-19, medRxiv, 2021.
   Google Scholar
• A.V. Sen'kova, I.A. Savin, E.V. Brenner, M.A. Zenkova and A.V. Markov, Core genes involved in the regulation of acute lung injury and their association with COVID-19 and tumor progression: a bioinformatics and experimental study, PLoS ONE. 16 (2021), p. e0260450.
   PubMed Web of Science ®Google Scholar
• P.P. Sfikakis, K.-M. Verrou, G. Ampatziadis-Michailidis, O. Tsitsilonis, D. Paraskevis, E. Kastritis, E. Lianidou, P. Moutsatsou, E. Terpos, I. Trougakos, V. Chini, M. Manoloukos, P. Moulos, G.A. Pavlopoulos, G. Kollias, P. Hatzis and M.A. Dimopoulos, Blood transcriptomes of Anti-SARS-CoV-2 antibody-positive healthy individuals who experienced asymptomatic versus clinical infection, Front. Immunol. 12 (2021), p. 746203.
   PubMed Web of Science ®Google Scholar
• H. Shaath and N.M. Alajez, Identification of PBMC-based molecular signature associational with COVID-19 disease severity, Heliyon 7 (2021), p. e06866.
   PubMed Web of Science ®Google Scholar
• A. Sharma, Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic data, Gene 788 (2021), p. 145665.
   PubMed Web of Science ®Google Scholar
• B. Shen, X. Yi, Y. Sun, X. Bi, J. Du, C. Zhang, S. Quan, F. Zhang, R. Sun, L. Qian, W. Ge, W. Liu, S. Liang, H. Chen, Y. Zhang, J. Li, J. Xu, Z. He and T. Guo, Proteomic and metabolomic characterization of COVID-19 patient sera, Cell 182 (2020), pp. 59–72.
   PubMed Web of Science ®Google Scholar
• E. Sotoudeh and H. Sotoudeh, A hypothesis about the role of fetal hemoglobin in COVID-19, Med. Hypotheses. 144 (2020), p. 109994.
   PubMed Web of Science ®Google Scholar
• Y. Su, D. Chen, D. Yuan, C. Lausted, J. Choi, C.L. Dai, V. Voillet, V.R. Duvvuri, K. Scherler, P. Troisch, P. Baloni, G. Qin, B. Smith, S.A. Kornilov, C. Rostomily, A. Xu, J. Li, S. Dong and J.R. Heath, Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19, Cell 183 (2020), pp. 1479–1495.
   PubMed Web of Science ®Google Scholar
• S. Sur, M. Khatun, R. Steele, T.S. Isbell, R. Ray and R.B. Ray, Exosomes from COVID-19 patients carry tenascin-C and fibrinogen-β in triggering inflammatory signals in cells of distant organ, Int. J. Mol. Sci. 22 (2021), p. 3184.
   PubMed Web of Science ®Google Scholar
• S. Tahaghoghi-Hajghorbani, P. Zafari, E. Masoumi, M. Rajabinejad, R. Jafari-Shakib, B. Hasani and A. Rafiei, The role of dysregulated immune responses in COVID-19 pathogenesis, Virus Res. 290 )2020), p. 198197.
   PubMed Web of Science ®Google Scholar
• I. Thevarajan, T.H.O. Nguyen, M. Koutsakos, J. Druce, L. Caly, C.E. van de Sandt, X. Jia, S. Nicholson, M. Catton, B. Cowie, S.Y.C. Tong, S.R. Lewin and K. Kedzierska, Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19, Nat. Med. 26 (2020), pp. 453–455.
   PubMed Web of Science ®Google Scholar
• L.A. Vella, J.R. Giles, A.E. Baxter, D.A. Oldridge, C. Diorio, L. Kuri-Cervantes, C. Alanio, M.B. Pampena, J.E. Wu, Z. Chen, Y.J. Huang, E.M. Anderson, S. Gouma, K.O. McNerney, J. Chase, C. Burudpakdee, J.H. Lee, S.A. Apostolidis, A.C. Huang, D. Mathew, O. Kuthuru, E.C. Goodwin, M.E. Weirick, M.J. Bolton, C.P. Arevalo, A. Ramos, C.J. Jasen, P.E. Conrey, S. Sayed, H.M. Giannini, K. D'Andrea, N.J. Meyer, E.M. Behrens, H. Bassiri, S.E. Hensley, S.E. Henrickson, D.T. Teachey, M.R. Betts and E.J. Wherry, Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19, Sci. Immunol. 6 (2021), p. eabf7570.
   PubMed Web of Science ®Google Scholar
• X. Wang, Y. Wen, X. Xie, Y. Liu, X. Tan, Q. Cai, Y. Zhang, L. Cheng, G. Xu, S. Zhang, H. Wang, L. Wei, X. Tang, F. Qi, J. Zhao, J. Yuan, L. Liu, P. Zhu, F. Ginhoux, S. Zhang, T. Cheng and Z. Zhang, Dysregulated hematopoiesis in bone marrow marks severe COVID-19, Cell. Discov. 7 (2021), pp. 1–18.
   PubMed Web of Science ®Google Scholar
• E. Wauters, P. Van Mol, A.D. Garg, S. Jansen, Y. Van Herck, L. Vanderbeke, A. Bassez, B. Boeckx, B. Malengier-Devlies, A. Timmerman, T. Van Brussel, T. Van Buyten, R. Schepers, E. Heylen, D. Dauwe, C. Dooms, J. Gunst, G. Hermans, P. Meersseman, D. Testelmans, J. Yserbyt, S. Tejpar, W. De Wever, P. Matthys, J. Neyts, J. Wauters, J. Qian and D. Lambrechts, Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages, Cell. Res. 31 (2021), pp. 272–290.
   PubMed Web of Science ®Google Scholar
• Z. Wicik, C. Eyileten, D. Jakubik, S.N. Simões, D.C. Martins, R. Pavão, J.M. Siller-Matula and M. Postula, ACE2 interaction networks in COVID-19: a physiological framework for prediction of outcome in patients with cardiovascular risk factors, J. Clin. Med. 9 (2020), p. 3743.
   PubMed Web of Science ®Google Scholar
• A.J. Wilk, M.J. Lee, B. Wei, B. Parks, R. Pi, G.J. Martínez-Colón, T. Ranganath, N.Q. Zhao, S. Taylor, W. Becker, D. Jimenez-Morales, A.L. Blomkalns, R. O'Hara, E.A. Ashley, K.C. Nadeau, S. Yang, S. Holmes, M. Rabinovitch, A.J. Rogers, W.J. Greenleaf and C.A. Blish, Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19, J. Exp. Med. 218 (2021), p. e20210582.
   PubMed Web of Science ®Google Scholar
• Z. Wu and J.M. McGoogan, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China summary of a report of 72314 cases from the Chinese center for disease control and prevention, JAMA Insights 323 (2020), pp. 1239–1242.
   Google Scholar
• B. Yang, J.A. Fulcher, J. Ahn, M. Berro, D. Goodman-Meza, K. Dhody, J.B. Sacha, A. Naeim and O.O Yang, Clinical characteristics and outcomes of COVID-19 patients receiving compassionate use leronlimab, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 73 (2020), pp. e4082–e4089.
   Web of Science ®Google Scholar
• H.-L. Zeng, D. Chen, J. Yan, Q. Yang, Q.-Q. Han, S.-S. Li and L. Cheng, Proteomic characteristics of bronchoalveolar lavage fluid in critical COVID-19 patients, FEBS. J. 288 (2021), pp. 5190–5200.
   PubMed Web of Science ®Google Scholar
• J.-Y. Zhang, X.-M. Wang, X. Xing, Z. Xu, C. Zhang, J.-W. Song, X. Fan, P. Xia, J.-L. Fu, S.-Y. Wang, R.-N. Xu, X.-P. Dai, L. Shi, L. Huang, T.-J. Jiang, M. Shi, Y. Zhang, A. Zumla, M. Maeurer, F. Bai and F.-S. Wang, Single-cell landscape of immunological responses in patients with COVID-19, Nat. Immunol. 21 (2020), pp. 1107–1118.
   PubMed Web of Science ®Google Scholar
• Y. Zhang, J. Tian, W. Shen, P. Li, C. He, G. Peng, R. Ren and Z. Zhao, Long term longitudinal analysis of peripheral blood transcriptome in COVID-19 patients, 2020. Available at SSRN 3658467.
   Google Scholar
• Y. Zhou, Y. Hou, J. Shen, R. Mehra, A. Kallianpur, D.A. Culver, M.U. Gack, S. Farha, J. Zein, S. Comhair, C. Fiocchi, T. Stappenbeck, T. Chan, C. Eng, J.U. Jung, L. Jehi, S. Erzurum and F. Cheng, A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19, PLoS Biol. 18 (2020), p. e3000970.
   PubMed Web of Science ®Google Scholar
• Z. Zhou, L. Ren, L. Zhang, J. Zhong, Y. Xiao, Z. Jia, L. Guo, J. Yang, C. Wang, S. Jiang, D. Yang, G. Zhang, H. Li, F. Chen, Y. Xu, M. Chen, Z. Gao, J. Yang, J. Dong, B. Liu, X. Zhang, W. Wang, K. He, Q. Jin, M. Li and J. Wang, Overly exuberant innate immune response to SARS-CoV-2 infection, SSRN, 2020.
   Google Scholar